Darzalex

Darzalex ATC Classification

daratumumab

Manufacturer:

Cilag AG

Distributor:

Johnson & Johnson
Full Prescribing Info
ATC Classification
L01FC01 - daratumumab ; Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in